<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[Lucence Diagnostics Pte Ltd 보도자료 - 뉴스와이어]]></title><link>https://www.newswire.co.kr/?md=A10&amp;act=article&amp;no=34778></link><description><![CDATA[Lucence Diagnostics Pte Ltd 보도자료 - 뉴스와이어 RSS 서비스]]></description><lastBuildDate>Tue, 14 Apr 2026 16:38:55 +0900</lastBuildDate><copyright>Copyright (c) 2004~2026 Korea Newswire All rights reserved</copyright><image><url><![CDATA[https://file.newswire.co.kr/data/upfile/company_img/2020/03/12_3554238800_20200322154421_1189992360.jpg]]></url></image><language>ko-KR</language><item><title><![CDATA[Lucence, A*STAR Share Study Data Showing SAFER™ Sample Saliva Collection Kit for COVID-19 Inactivates Collected Virus]]></title><link>https://www.newswire.co.kr/newsRead.php?no=906481</link><description><![CDATA[SINGAPORE--(Business Wire/Korea Newswire)--Molecular diagnostics company Lucence and the Agency for Science, Technology and Research (A*STAR) today announced study results indicating that the reagent used in Lucence’s SAFER Sample saliva collection kit inactivates SARS-CoV-2 within 45 seconds of sample collection. This proprietary reagent also stabilizes viral RNA at room temperature for...]]></description><pubDate>Wed, 17 Jun 2020 15:20:00 +0900</pubDate></item><item><title><![CDATA[루센스와 A*STAR, ‘세이퍼 샘플’ 타액 채집 키트가 채집된 COVID-19 바이러스를 비활성화한 것으로 나타난 연구 데이터 공동 발표]]></title><link>https://www.newswire.co.kr/newsRead.php?no=906482</link><description><![CDATA[싱가포르--(Business Wire/뉴스와이어)--분자진단 기업 루센스(Lucence)와 싱가포르 과학기술연구청(Agency for Science, Technology and Research, 이하 ‘A*STAR’)이 루센스의 ‘세이퍼 샘플(SAFER[Stabilization of nucleic Acid Formulation for Evaluation of RNA] Sample)’ 타액 채집 키트에 사용되는 시약이 중증급성호흡기증후군-코로나바이러스-2(SARS-CoV-2)를 샘플 채집 후 45초 이내에 비활성화한 것으로...]]></description><image><url><![CDATA[https://file.newswire.co.kr/data/datafile2/thumb/2020/06/3554238800_20200617150929_7171834104.jpg]]></url></image><pubDate>Wed, 17 Jun 2020 15:20:00 +0900</pubDate></item><item><title><![CDATA[Genomics Company Lucence Develops Viral Sample Collection Medical Device for COVID-19 Diagnosis and Surveillance]]></title><link>https://www.newswire.co.kr/newsRead.php?no=902813</link><description><![CDATA[SINGAPORE--(Business Wire/Korea Newswire)--Molecular diagnostics company Lucence announced today the development of the SAFER-Sample (Stabilization of nucleic Acid Formulation for Evaluation of RNA) kit, a sample collection medical device to facilitate more accessible testing of viral infections such as COVID-19.  Presently, definitive diagnosis of RNA viral infections such as COVID-19 r...]]></description><pubDate>Mon, 23 Mar 2020 11:53:28 +0900</pubDate></item><item><title><![CDATA[유전체학 기업 루센스, 코로나19 진단 및 감시 위한 바이러스 검체 채집 의료기기 개발]]></title><link>https://www.newswire.co.kr/newsRead.php?no=902814</link><description><![CDATA[싱가포르--(Business Wire/뉴스와이어)--분자 진단 기업 루센스(Lucence)가 신종코로나바이러스(코로나19)와 같은 바이러스 감염 검사를 용이하게 하는 검체 채집 의료 장비 ‘세이퍼 샘플(SAFER(Stabilization of nucleic Acid Formulation for Evaluation of RNA)-Sample)’ 키트를 개발했다고 20일 발표했다.   현재 코로나19와 같은 RNA 바이러스 감염을 확진하려면 호흡기 감염 환자의 비강 및/또는 인후 면봉 ...]]></description><image><url><![CDATA[https://file.newswire.co.kr/data/datafile2/thumb/2020/03/3554238800_20200323114533_5558514568.jpg]]></url></image><pubDate>Mon, 23 Mar 2020 11:52:19 +0900</pubDate></item></channel></rss>